GTR Home > Tests > Search results - Muscular dystrophy, limb-girdle, type 2j

Apply filters

Showing test for 1 condition

reset

Compare labs

  • Hide states

GTR test search results for C1837342[DISCUI]

C Clinical test, R Research test

Showing 1 to 18 of 18 tests for 1 condition in 5 labs

CCongenital Myopathy Deletion/Duplication Analysis

Lab: Genetic Services Laboratory University of Chicago Chicago, Illinois, United States
Total conditions (25)
Total targets (17)

CLimb-Girdle Muscular Dystrophy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (22)
Total targets (24)

CAutosomal Recessive Limb-Girdle Muscular Dystrophy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (17)
Total targets (18)

CTTN Gene Sequencing

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (7)

CPan Cardiomyopathy Panel (51 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (89)
Total targets (51)

CDCM Panel (27 Genes)

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (59)
Total targets (27)

CLimb Girdle Muscular Dystrophy, Type 2J and Tibial Muscular Dystrophy via the TTN Gene (exons 307 - 312)

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CLimb-Girdle Muscular Dystrophy: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (66)
Total targets (22)

CExpanded Neuromuscular Disorders: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (154)
Total targets (79)

CNeuromuscular Disorders: Gene Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (102)
Total targets (46)

CDilated Cardiomyopathy: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (72)
Total targets (25)

CCardiomyopathy: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (229)
Total targets (104)

CSudden Death Syndrome NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Total conditions (187)
Total targets (67)

CNeuromuscular NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (126)
Total targets (50)

CPan-Cardiovascular NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (239)
Total targets (100)

CMuscular Dystrophies NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (73)
Total targets (29)

Showing 1 to 18 of 18 tests for 1 condition in 5 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk